Second-Generation Tau PET Tracer [18F]PI-2620 Shows Promise as a Diagnostic Imaging Biomarker for Progressive Supranuclear Palsy and Corticobasal Degeneration: A Meta-Analysis of 29 Studies.

https://pubmed.ncbi.nlm.nih.gov/38094644

This meta-analysis of 29 studies suggests that the second-generation tau PET tracer [18F]PI-2620 shows promise as a diagnostic imaging biomarker for progressive supranuclear palsy and corticobasal degeneration, outperforming first-generation tracers in differentiating these atypical parkinsonisms from healthy controls.